Cover Image
Market Research Report
Product code 
1045219

Mesenchymal Stem Cells Market Research Report by Type, by Indication, by Source of Isolation, by Application, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 185 Pages | Delivery time: 1-2 business days

Price

Back to Top
Mesenchymal Stem Cells Market Research Report by Type, by Indication, by Source of Isolation, by Application, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: January 6, 2022
360iResearch LLP
Content info: 185 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global Mesenchymal Stem Cells Market size was estimated at USD 2,415.13 million in 2020 and expected to reach USD 2,731.51 million in 2021, at a CAGR 13.46% to reach USD 5,847.89 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Mesenchymal Stem Cells to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the market was studied across Allogeneic and Autologous.
  • Based on Indication, the market was studied across Bone & Cartilage Repair, Cancer, Cardiovascular Disease, GvHD, Inflammatory And Immunological Disease, and Liver Diseases.
  • Based on Source of Isolation, the market was studied across Adipose Tissues, Bone & Cartilage Repair, Bone Marrow, Cancer, Cardiovascular Disease, Cord Blood, Fallopian Tube, Fetal Liver, GvHD, Inflammatory And Immunological Disease, Liver Diseases, Lung, and Peripheral Blood.
  • Based on Application, the market was studied across Disease Modeling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, and Toxicology Studies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Mesenchymal Stem Cells Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Mesenchymal Stem Cells Market, including Aastrom Biosciences, Advanced Cell Technology Incorporated, American Type Culture Collection, Axol Biosciences Ltd., BrainStorm Cell Therapeutics Inc., Cell Applications, Inc., Celprogen, Inc., Cyagen Biosciences, Inc., Cytori Therapeutics Inc, EMD Millipore Corporation, Genlantis, Inc., Lonza AG, Mesenchymal Stem Cells, PromoCell GmbH, ScienCell Research Laboratories, Smith+Nephew, Stemcell Technologies Inc., Stemedica Cell Technologies Inc, and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Mesenchymal Stem Cells Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Mesenchymal Stem Cells Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Mesenchymal Stem Cells Market?
  • 4. What is the competitive strategic window for opportunities in the Global Mesenchymal Stem Cells Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Mesenchymal Stem Cells Market?
  • 6. What is the market share of the leading vendors in the Global Mesenchymal Stem Cells Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Mesenchymal Stem Cells Market?
Table of Contents
Product Code: MRR-B973EDD5ED83

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in mesenchymal stem cell based research
      • 5.1.1.2. Rising geriatric population coupled with growth in chronic diseases
      • 5.1.1.3. Continuously evolving landscape of stem cell therapies
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of therapeutic implication related to vitro properties of stem cell
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging applications of mesenchymal stem cell
      • 5.1.3.2. Rising collaborations and partnerships and rising innovation of mesenchymal stem cell products.
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges related to MSC developments
      • 5.1.4.2. Ethical & safety issues associated with human MSC therapy
  • 5.2. Cumulative Impact of COVID-19

6. Mesenchymal Stem Cells Market, by Type

  • 6.1. Introduction
  • 6.2. Allogeneic
  • 6.3. Autologous

7. Mesenchymal Stem Cells Market, by Indication

  • 7.1. Introduction
  • 7.2. Bone & Cartilage Repair
  • 7.3. Cancer
  • 7.4. Cardiovascular Disease
  • 7.5. GvHD
  • 7.6. Inflammatory And Immunological Disease
  • 7.7. Liver Diseases

8. Mesenchymal Stem Cells Market, by Source of Isolation

  • 8.1. Introduction
  • 8.2. Adipose Tissues
  • 8.3. Bone & Cartilage Repair
  • 8.4. Bone Marrow
  • 8.5. Cancer
  • 8.6. Cardiovascular Disease
  • 8.7. Cord Blood
  • 8.8. Fallopian Tube
  • 8.9. Fetal Liver
  • 8.10. GvHD
  • 8.11. Inflammatory And Immunological Disease
  • 8.12. Liver Diseases
  • 8.13. Lung
  • 8.14. Peripheral Blood

9. Mesenchymal Stem Cells Market, by Application

  • 9.1. Introduction
  • 9.2. Disease Modeling
  • 9.3. Drug Development & Discovery
  • 9.4. Stem Cell Banking
  • 9.5. Tissue Engineering
  • 9.6. Toxicology Studies

10. Americas Mesenchymal Stem Cells Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Mesenchymal Stem Cells Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand

12. Europe, Middle East & Africa Mesenchymal Stem Cells Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Aastrom Biosciences
  • 14.2. Advanced Cell Technology Incorporated
  • 14.3. American Type Culture Collection
  • 14.4. Axol Biosciences Ltd.
  • 14.5. BrainStorm Cell Therapeutics Inc.
  • 14.6. Cell Applications, Inc.
  • 14.7. Celprogen, Inc.
  • 14.8. Cyagen Biosciences, Inc.
  • 14.9. Cytori Therapeutics Inc
  • 14.10. EMD Millipore Corporation
  • 14.11. Genlantis, Inc.
  • 14.12. Lonza AG
  • 14.13. Mesenchymal Stem Cells
  • 14.14. PromoCell GmbH
  • 14.15. ScienCell Research Laboratories
  • 14.16. Smith+Nephew
  • 14.17. Stemcell Technologies Inc.
  • 14.18. Stemedica Cell Technologies Inc
  • 14.19. Thermo Fisher Scientific, Inc.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL MESENCHYMAL STEM CELLS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL MESENCHYMAL STEM CELLS MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
  • FIGURE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2027
  • FIGURE 6. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, 2018-2027 (USD MILLION)
  • FIGURE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2027 (USD MILLION)
  • FIGURE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2020 VS 2027 (%)
  • FIGURE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2020 VS 2027 (USD MILLION)
  • FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2027
  • FIGURE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, 2018-2027 (USD MILLION)
  • FIGURE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 15. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
  • FIGURE 16. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 17. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2027 (USD MILLION)
  • FIGURE 18. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 19. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, 2018-2027 (USD MILLION)
  • FIGURE 20. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 21. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY AND IMMUNOLOGICAL DISEASE, 2018-2027 (USD MILLION)
  • FIGURE 22. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY AND IMMUNOLOGICAL DISEASE, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 23. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, 2018-2027 (USD MILLION)
  • FIGURE 24. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 25. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2020 VS 2027 (%)
  • FIGURE 26. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2020 VS 2027 (USD MILLION)
  • FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2027
  • FIGURE 28. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUES, 2018-2027 (USD MILLION)
  • FIGURE 29. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 30. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, 2018-2027 (USD MILLION)
  • FIGURE 31. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 32. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, 2018-2027 (USD MILLION)
  • FIGURE 33. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 34. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
  • FIGURE 35. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 36. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2027 (USD MILLION)
  • FIGURE 37. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 38. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CORD BLOOD, 2018-2027 (USD MILLION)
  • FIGURE 39. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CORD BLOOD, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 40. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FALLOPIAN TUBE, 2018-2027 (USD MILLION)
  • FIGURE 41. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FALLOPIAN TUBE, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 42. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FETAL LIVER, 2018-2027 (USD MILLION)
  • FIGURE 43. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FETAL LIVER, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 44. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, 2018-2027 (USD MILLION)
  • FIGURE 45. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 46. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY AND IMMUNOLOGICAL DISEASE, 2018-2027 (USD MILLION)
  • FIGURE 47. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY AND IMMUNOLOGICAL DISEASE, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 48. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, 2018-2027 (USD MILLION)
  • FIGURE 49. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 50. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LUNG, 2018-2027 (USD MILLION)
  • FIGURE 51. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LUNG, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 52. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, 2018-2027 (USD MILLION)
  • FIGURE 53. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 54. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
  • FIGURE 55. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
  • FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2027
  • FIGURE 57. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2027 (USD MILLION)
  • FIGURE 58. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 59. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, 2018-2027 (USD MILLION)
  • FIGURE 60. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 61. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STEM CELL BANKING, 2018-2027 (USD MILLION)
  • FIGURE 62. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STEM CELL BANKING, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 63. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2027 (USD MILLION)
  • FIGURE 64. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 65. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, 2018-2027 (USD MILLION)
  • FIGURE 66. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 67. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 68. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 69. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 70. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 71. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 72. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 73. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 74. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 75. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 76. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 77. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 78. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 79. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 80. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 81. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 82. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 83. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 84. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 85. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 86. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 87. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 88. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 89. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 90. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 91. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 92. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 93. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 94. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 95. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 96. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 97. GLOBAL MESENCHYMAL STEM CELLS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 98. GLOBAL MESENCHYMAL STEM CELLS MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 99. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MESENCHYMAL STEM CELLS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL MESENCHYMAL STEM CELLS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY AND IMMUNOLOGICAL DISEASE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2027 (USD MILLION)
  • TABLE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 20. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FALLOPIAN TUBE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FETAL LIVER, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 22. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 23. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY AND IMMUNOLOGICAL DISEASE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 24. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LUNG, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 26. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 27. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 28. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 30. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STEM CELL BANKING, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 31. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 32. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 33. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 34. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 35. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 36. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 37. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 38. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 40. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 41. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 42. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 43. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 44. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 45. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 46. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 47. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 48. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 49. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 50. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 51. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 52. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 53. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 54. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 55. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 56. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 57. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 58. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 59. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 60. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 61. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 62. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 63. GLOBAL MESENCHYMAL STEM CELLS MARKET: SCORES
  • TABLE 64. GLOBAL MESENCHYMAL STEM CELLS MARKET: BUSINESS STRATEGY
  • TABLE 65. GLOBAL MESENCHYMAL STEM CELLS MARKET: PRODUCT SATISFACTION
  • TABLE 66. GLOBAL MESENCHYMAL STEM CELLS MARKET: RANKING
  • TABLE 67. GLOBAL MESENCHYMAL STEM CELLS MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 68. GLOBAL MESENCHYMAL STEM CELLS MARKET: MERGER & ACQUISITION
  • TABLE 69. GLOBAL MESENCHYMAL STEM CELLS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 70. GLOBAL MESENCHYMAL STEM CELLS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 71. GLOBAL MESENCHYMAL STEM CELLS MARKET: INVESTMENT & FUNDING
  • TABLE 72. GLOBAL MESENCHYMAL STEM CELLS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 73. GLOBAL MESENCHYMAL STEM CELLS MARKET: LICENSE & PRICING